非酒精性脂肪性肝病中自噬与铁死亡相互作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.08.1294

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (8): 1294-1298.doi: 10.16352/j.issn.1001-6325.2023.08.1294

非酒精性脂肪性肝病中自噬与铁死亡相互作用的研究进展

李想, 李晔^*

昆明理工大学医学院基础医学系,云南昆明 650500

收稿日期:2022-06-15 修回日期:2022-11-13 出版日期:2023-08-05 发布日期:2023-07-26
通讯作者: ^*liye918@gmail.com
基金资助:
国家自然科学基金(81460167);云南省教育厅科学研究基金(2019J0041);云南省万人计划“青年拔尖人才”专项(YNWR-QNBJ-2018-126)

Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease

LI Xiang, LI Ye^*

Department of Basic Medicine, Medical School, Kunming University of Science and Technology, Kunming 650500, China

Received:2022-06-15 Revised:2022-11-13 Online:2023-08-05 Published:2023-07-26
Contact: ^*liye918@gmail.com

摘要/Abstract

摘要： 自噬和铁死亡作为细胞中重要的生物学过程,在肝细胞中维持脂质累积稳态、氧化应激和脂质过氧化平衡方面起到重要作用。本文从肝脏脂肪代谢过程中,自噬过程直接影响脂质异常累积,到其与铁死亡氧化应激和脂质过氧化的关系,以及自噬与铁死亡的相互作用,从而对非酒精性脂肪性肝病(NAFLD)病程的影响进行综述。研究自噬与铁死亡相互作用或许能为NAFLD治疗提供一些新思路。

关键词: 非酒精性脂肪肝病, 自噬, 铁死亡, 脂代谢

Abstract: In hepatocytes, autophagy and ferroptosis, as important biological processes in cells, play important roles in maintaining lipid accumulation homeostasis, oxidative stress and lipid peroxidation balance. Here we reviewed the impact of autophagy on the abnormal lipids accumulation in the process of liver lipid metabolism, and its relationship with ferroptosis, which was marked by oxidative stress and lipid peroxidation. The impact of the interaction between autophagy and ferroptosis on the course of non-alcoholic fatty liver disease (NAFLD) might provide some new ideas for the treatment of NAFLD.

Key words: non-alcoholic fatty liver disease, autophagy, ferroptosis, lipid metabolism

中图分类号:

李想, 李晔. 非酒精性脂肪性肝病中自噬与铁死亡相互作用的研究进展[J]. 基础医学与临床, 2023, 43(8): 1294-1298.

LI Xiang, LI Ye. Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease[J]. Basic & Clinical Medicine, 2023, 43(8): 1294-1298.

参考文献 25

[1]	Zhang C, Wang J, Ding S, et al. Relationship between lifestyle and metabolic factors and carotid atherosclerosis: a survey of 47,063 fatty and non-fatty liver patients in China[J]. Front Cardiovasc Med, 2022, 9:935185. doi: 10.3389/fcvm.2022.935185.
[2]	Lad A, Hunyadi J, Connolly J, et al. Antioxidant therapy significantly attenuates hepatotoxicity following low dose exposure to microcystin-LR in a murine model of diet-induced non-alcoholic fatty liver disease[J]. Antioxidants (Basel), 2022, 11:1625. doi: 10.3390/antiox11081625.
[3]	Chen TQ, Deng YF, Wang YY, et al. Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-κB signaling pathway[J]. Biochem Biophys Res Commun, 2022, 626:167-174.
[4]	Jiang JJ, Zhang GF, Zheng JY, et al. Targeting mitochondrial ROS-mediated ferroptosis by quercetin alleviates high-fat diet-induced hepatic lipotoxicity[J]. Front Pharmacol, 2022, 13:876550. doi: 10.3390/antiox11081625.
[5]	Bai J, Liu T, Tu B, et al. Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis[J]. Autophagy, 2023, 19:632-643.
[6]	Yan H, Zhuang M, Xu X, et al. Autophagy and its mediated mitochondrial quality control maintain pollen tube growth and male fertility in Arabidopsis[J]. Autophagy, 2023, 19:768-783.
[7]	Kannangara AR, Andersen JL. Mapping the proximity interactome of ATG9A reveals unexpected dynamics of ULK1 complex proteins[J]. Autophagy, 2022, 18:2754-2755.
[8]	徐玲,马红艳,杨军,等. 高脂饮食通过p-AMPK/mTOR信号通路下调小鼠肝细胞自噬水平[J].基础医学与临床,2018,38:37-41.
[9]	Harada M, Hanada S, Toivola DM, et al. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation[J]. Hepatology, 2008, 47:2026-2035.
[10]	Zhou F, Ding M, Gu Y, et al. Aurantio-Obtusin attenuates non-alcoholic fatty liver disease through AMPK-mediated autophagy and fatty acid oxidation pathways[J]. Front Pharmacol, 2021, 12:826628. doi: 10.3389/fphar.2021.826628.
[11]	Zhang H, Lu J, Liu H, et al. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease[J]. Pharmacol Res, 2021, 174:105964. doi: 10.1016/j.phrs.2021.105964.
[12]	Luo T, Zheng Q, Shao L, et al. Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo[J]. Angew Chem Int Ed Engl, 2022, 4:e202206277. doi: 10.1002/anie.202206277.
[13]	Song X, Liu J, Kuang F, et al. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis[J]. Cell Rep, 2021, 34:108767. doi: 10.1016/j.celrep.2021.108767.
[14]	Li X, Wang TX, Huang X, et al. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liverlipotoxicity[J]. Liver Int, 2020, 40:1378-1394.
[15]	Loguercio C, De Girolamo V, de Sio I, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects[J]. J Hepatol, 2001, 35:568-574.
[16]	Qi J, Kim JW, Zhou Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice[J]. Am J Pathol, 2020, 190:68-81.
[17]	Yao C, Lan D, Li X, et al. Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis[J]. Microbes Infect, 2022, 17:105040. doi: 10.1016/j.micinf.2022.105040.
[18]	da Silva Lima N, Fondevila MF, Nóvoa E, et al. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function[J]. J Hepatol, 2022, 76:11-24.
[19]	Zhang R, Chu K, Zhao N, et al. Corilagin alleviates nonalcoholic fatty liver disease in high-fat diet-induced C57BL/6 mice by ameliorating oxidative stress and restor-ing autophagic Flux[J]. Front Pharmacol, 2019,10:1693. doi: 10.3389/fphar.2019.01693.
[20]	Kang R, Zhu S, Zeh HJ, et al. BECN1 is a new driver of ferroptosis[J]. Autophagy, 2018, 14:2173-2175.
[21]	Li J, Yuan J, Li Y, et al. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy[J]. Phytomedicine, 2022, 106:154411. doi: 10.1016/j.phymed.2022.154411.
[22]	Gao H, Bai Y, Jia Y, et al. Ferroptosis is a lysosomal cell death process[J]. Biochem Biophys Res Commun, 2018, 503:1550-1556.
[23]	Yi J, Wu S, Tan S, et al. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis[J]. Cell Death Discov, 2021, 7:374. doi: 10.1038/s41420-021-00768-7.
[24]	Zhang Z, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells[J]. Autophagy, 2020, 16:1482-1505.
[25]	Pennisi G, Enea M, Romero-Gomez M, et al. Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis[J]. Aliment Pharmacol Ther, 2022, 55:604-615.

非酒精性脂肪性肝病中自噬与铁死亡相互作用的研究进展

Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	肖艳红, 姜明东, 林叶远, 冉灿, 梁博. 灯盏花乙素抑制人前列腺癌细胞系PC-3的增殖和迁移[J]. 基础医学与临床, 2024, 44(9): 1229-1235.
[2]	祖力皮亚·阿布拉, 赵强, 张泰民, 李甜. 马里苷减轻高糖诱导的大鼠心肌细胞系H9c2损伤[J]. 基础医学与临床, 2024, 44(9): 1269-1273.
[3]	周昌东, 林洋, 孙凯, 田玉新. 敲降lncRNA UCA1降低人膀胱癌细胞系T24对吉西他滨耐药[J]. 基础医学与临床, 2024, 44(8): 1113-1119.
[4]	张祥鑫, 李文. 线粒体自噬在肝脏缺血再灌注损伤中的作用[J]. 基础医学与临床, 2024, 44(6): 877-881.
[5]	张玉苓, 张珂, 许艇, 张庆. 胎儿生长受限孕妇胎盘自噬相关蛋白表达水平及其临床意义[J]. 基础医学与临床, 2024, 44(4): 528-532.
[6]	杨铠菲, 朱静格, 张洋洋, 赵俊果, 高雨悦, 胡焕焕, 姬国杰. 索拉菲尼诱导的细胞凋亡和自噬对HeLa细胞耐药性的影响[J]. 基础医学与临床, 2024, 44(4): 467-473.
[7]	肖艳新, 刘岩, 许岭翎, 周亚茹. 铁死亡在非酒精性脂肪性肝病发病中作用的研究进展[J]. 基础医学与临床, 2024, 44(2): 260-264.
[8]	田宗源, 李展, 刘瑞霞. TERT调控线粒体氧化应激在疾病中的作用[J]. 基础医学与临床, 2024, 44(10): 1436-1441.
[9]	孙立杰, 郝丹丹. 诱导肝星状细胞铁死亡治疗肝纤维化的研究进展[J]. 基础医学与临床, 2024, 44(1): 108-113.
[10]	吴国嘏, 翟书杰, 孙笑, 黄怡然, 李咏梅, 孙丽. 羟酰辅酶A脱氢酶在癌中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(1): 119-123.
[11]	李庆菊, 于然, 陈佳佳, 陈皓瑜, 宋坚, 王万鹏. 雷帕霉素减轻碘佛醇诱导的模型大鼠急性肾损伤[J]. 基础医学与临床, 2024, 44(1): 31-36.
[12]	徐桂萍, 陈雪莹, 张宇轩, 麦丽帕特·伊力艾克拜尔. 利多卡因对急性肺损伤模型大鼠肺组织线粒体自噬的影响[J]. 基础医学与临床, 2023, 43(9): 1394-1398.
[13]	宋星明, 哈力沙·艾日肯江, 迪丽胡玛尔·阿布来提, 高颖. 内皮脂肪酶作为冠心病治疗靶点的研究进展[J]. 基础医学与临床, 2023, 43(9): 1443-1447.
[14]	郝丹丹, 张垒, 白春英. 靶向铁死亡治疗非酒精性脂肪性肝病的研究进展[J]. 基础医学与临床, 2023, 43(8): 1317-1321.
[15]	楚晓云, 蔡成. 铁死亡在新生儿急性肺损伤中作用机制的研究进展[J]. 基础医学与临床, 2023, 43(6): 1008-1011.